title: Differential regulation of expression of cytosolic and mitochondrial thioredoxin reductase in rat liver and kidney.
abstract: Adequate supply of selenium (Se) is critical for synthesis of selenoproteins through selenocysteine insertion mechanism. To explore this process we investigated the expression of the cytosolic and mitochondrial isoenzymes of thioredoxin reductase (TrxR1 and TrxR2) in response to altered Se supply. Rats were fed diets containing different quantities of selenium and the levels of TrxR1 and TrxR2 protein and their corresponding mRNAs were determined in liver and kidney. Expression of the two isoenzymes was differentially affected, with TrxR1 being more sensitive to Se depletion than TrxR2 and greater changes in liver than kidney. In order to determine if the selenocysteine incorporation sequence (SECIS) element was critical in this response liver and kidney cell lines (H4 and NRK-52E) were transfected with reporter constructs in which expression of luciferase required read-through at a UGA codon and which contained either the TrxR1 or TrxR2 3'UTR, or a combination of the TrxR1 5' and 3'UTRs. Cell lines expressing constructs with the TrxR1 3'UTR demonstrated no response to restricted Se supply. In comparison the Se-deficient cells expressing constructs with the TrxR2 3'UTR showed considerably less luciferase activity than the Se-adequate cells. No disparity of response to Se supply was observed in the constructs containing the different TrxR1 5'UTR variants. The data show that there is a prioritisation of TrxR2 over TrxR1 during Se deficiency such that TrxR1 expression is more sensitive to Se supply than TrxR2 but this sensitivity of TrxR1 was not fully accounted for by TrxR1 5' or 3'UTR sequences when assessed using luciferase reporter constructs.
authors.affiliation: Vascular Health Programme, Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen AB21 9SB, UK.
authors.forename: L K
authors.initials: LK
authors.lastname: Crosley
authors.forename: C
authors.initials: C
authors.lastname: Méplan
authors.forename: F
authors.initials: F
authors.lastname: Nicol
authors.forename: A K
authors.initials: AK
authors.lastname: Rundlöf
authors.forename: E S J
authors.initials: ES
authors.lastname: Arnér
authors.forename: J E
authors.initials: JE
authors.lastname: Hesketh
authors.forename: J R
authors.initials: JR
authors.lastname: Arthur
mesh_terms: D000284:Administration, Oral; D000818:Animals; D002478:Cells, Cultured; D003600:Cytosol / Q000187:drug effects / Q000201:enzymology*; D004305:Dose-Response Relationship, Drug; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects / Q000502:physiology; D007668:Kidney / Q000187:drug effects / Q000201:enzymology*; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008928:Mitochondria / Q000187:drug effects / Q000201:enzymology*; D051381:Rats / Q000378:metabolism*; D012643:Selenium / Q000008:administration & dosage*; D013880:Thioredoxin-Disulfide Reductase / Q000378:metabolism*
chemical_list: D013880:Thioredoxin-Disulfide Reductase; D012643:Selenium